Lv11
40 积分 2024-04-22 加入
Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective
1个月前
已完结
A comprehensive review of immune checkpoint inhibitors for cancer treatment
1个月前
已完结
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
1个月前
已完结
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
1个月前
已完结
Possible protective role of panax ginseng on cisplatin-induced hepatotoxicity in adult male albino rats (Biochemical and Histological Study)
1个月前
已完结
Oxaliplatin-Mediated Increase in Spleen Size As a Biomarker for the Development of Hepatic Sinusoidal Injury
1个月前
已完结
Immune-mediated liver injury from checkpoint inhibitors: mechanisms, clinical characteristics and management
1个月前
已完结
Current state of the art: immunotherapy in esophageal cancer and gastroesophageal junction cancer
1个月前
已完结
Impact of perioperative liver dysfunction on in-hospital mortality and long-term survival in infective endocarditis patients
1个月前
已完结
Oesophageal cancer
2个月前
已完结
皖公网安备34019202002308
